| Dr Paul Kleeberg, MD | |
|
7811 128th St W, Apple Valley, MN 55124-6280 | |
| (952) 686-7734 | |
| Not Available |
| Full Name | Dr Paul Kleeberg |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 7811 128th St W, Apple Valley, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467401166 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34619 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Kleeberg, MD 7811 128th St W, Apple Valley, MN 55124-6280 Ph: (952) 686-7734 | Dr Paul Kleeberg, MD 7811 128th St W, Apple Valley, MN 55124-6280 Ph: (952) 686-7734 |
News Archive
Access Pharmaceuticals, Inc., today announced it has initiated a Phase I/II dose-escalating study of its proprietary, anti-cancer drug, Thiarabine, a nucleoside analog for patients with hematologic malignancies (cancers of the blood). The primary objective of the study is to determine the maximum tolerated dose (MTD) in two different dosing schedules with various leukemias and lymphomas and recommended Phase II dose. The program is being led by Hagop Kantarjian, M.D., Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.
Vistec Lithography, a leading supplier of advanced electron-beam lithography systems has announced today that the International Iberian Nanotechnology Laboratory (INL) in Braga, Portugal has placed an order for Vistec's electron-beam lithography system EBPG5200. The Portuguese Laboratory is the first fully international research organization in Europe in the field of nanoscience and nanotechnology.
Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an investigational atypical antipsychotic agent for the treatment of schizophrenia. The application, submitted on December 30, 2009, includes data from more than 40 clinical studies involving more than 2,500 lurasidone-treated patients.
The U.S. Food and Drug Administration has seized prescription drug orders shipped from abroad to more than 50 customers of I-Save-R-x, a program launched last year by Governor Rod Blagojevich, to help residents save money on prescription drugs.
› Verified 1 days ago
Jeffrey R Michell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15650 Cedar Ave, Apple Valley, MN 55124 Phone: 952-997-4177 | |
Stephen Joseph Craane, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15290 Pennock Ln, Apple Valley, MN 55124 Phone: 952-853-8800 Fax: 952-431-6966 | |
Todd Joseph Stolpman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14655 Galaxie Ave, Apple Valley, MN 55124 Phone: 952-432-6161 Fax: 952-432-7019 | |
Holly A Hett, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14655 Galaxie Ave, Apple Valley, MN 55124 Phone: 952-432-6161 Fax: 952-432-7019 | |
David P Dillon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15290 Pennock Ln, Apple Valley, MN 55124 Phone: 952-853-8800 Fax: 952-431-6966 | |
April Coming Hay, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15650 Cedar Ave, Apple Valley, MN 55124 Phone: 952-997-4100 | |
Christopher Balgobin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15650 Cedar Ave, Apple Valley, MN 55124 Phone: 952-997-4100 |